Ondansetron
C18H19N3O
293.36
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]- (±)-.
(±)-2,3-Dihydro-9-methyl-3-[(2-methylimidazol-1-yl)methyl]carbazol-4(1H)-one [99614-02-5]
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]- (±)-.
(±)-2,3-Dihydro-9-methyl-3-[(2-methylimidazol-1-yl)methyl]carbazol-4(1H)-one [99614-02-5]
» Ondansetron contains not less than 98.0 percent and not more than 102.0 percent of C18H19N3O, calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Ondansetron RSUSP Ondansetron Related Compound A RS
USP Ondansetron Related Compound C RS
USP Ondansetron Related Compound D RS